(UroToday.com) The first prostate cancer session at the 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting featured a number of case presentations focused on diagnosis and staging. The second of these, featuring a case presentation from Dr. Sandro Gaspar and a pro/con debate from Drs. Francesco Ceci and Henk van der Poel, examined the value of prostate-specific membrane antigen (PSMA) PET/CT compared to conventional imaging for the primary staging of patients with high-risk prostate cancer.